• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Less Is More: A 7-Day Course of Antibiotics Is the Evidence-Based Treatment for Pseudomonas aeruginosa Ventilator-Associated Pneumonia.

作者信息

Metersky Mark L, Klompas Michael, Kalil Andre C

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2023 Feb 18;76(4):750-752. doi: 10.1093/cid/ciac809.

DOI:10.1093/cid/ciac809
PMID:36196675
Abstract
摘要

相似文献

1
Less Is More: A 7-Day Course of Antibiotics Is the Evidence-Based Treatment for Pseudomonas aeruginosa Ventilator-Associated Pneumonia.少即是多：7天疗程抗生素是铜绿假单胞菌呼吸机相关性肺炎的循证治疗方法。
Clin Infect Dis. 2023 Feb 18;76(4):750-752. doi: 10.1093/cid/ciac809.
2
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.抗生素使用时长对铜绿假单胞菌呼吸机相关性肺炎患者临床事件的影响：一项随机对照研究的研究方案
Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3.
3
Improving the adequacy of empirical beta-lactam therapy for Pseudomonas aeruginosa ventilator-associated pneumonia.提高针对铜绿假单胞菌呼吸机相关性肺炎的经验性β-内酰胺类治疗的充分性。
Int J Antimicrob Agents. 2008 May;31(5):489-90. doi: 10.1016/j.ijantimicag.2008.01.001. Epub 2008 Mar 4.
4
Recurrent ventilator-associated pneumonia caused by "difficult to treat" resistance Pseudomonas aeruginosa.由“难治性”耐药铜绿假单胞菌引起的复发性呼吸机相关性肺炎。
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):117-119. doi: 10.37201/req/s01.25.2022. Epub 2022 Apr 22.
5
Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections.严重多重耐药铜绿假单胞菌感染的治疗。
Med Intensiva (Engl Ed). 2022 Sep;46(9):508-520. doi: 10.1016/j.medine.2022.06.014. Epub 2022 Jul 12.
6
Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.头孢洛扎-他唑巴坦用于治疗由耐黏菌素铜绿假单胞菌引起的呼吸机相关性感染。
Rev Esp Quimioter. 2017 Jun;30(3):224-228. Epub 2017 Mar 29.
7
Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.头孢洛扎/他唑巴坦治疗多重耐药铜绿假单胞菌引起的呼吸道感染
Clin Infect Dis. 2015 Sep 1;61(5):853-5. doi: 10.1093/cid/civ411. Epub 2015 May 28.
8
Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.雾化吸入妥布霉素治疗急性呼吸窘迫综合征患者的铜绿假单胞菌呼吸机相关性肺炎。
Pulm Pharmacol Ther. 2017 Aug;45:142-147. doi: 10.1016/j.pupt.2017.04.008. Epub 2017 Apr 24.
9
Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.耐抗生素铜绿假单胞菌：关注接受辅助通气患者的护理。
Future Microbiol. 2014;9(4):465-74. doi: 10.2217/fmb.14.7.
10
Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia.铜绿假单胞菌呼吸机相关性肺炎的继发感染。
Minerva Anestesiol. 2011 Oct;77(10):964-70.

引用本文的文献

1
Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial.重症监护病房患者严重多重耐药革兰阴性菌感染抗菌治疗7天与14天对比研究（OPTIMISE）：一项随机、开放标签、非劣效性临床试验
Crit Care. 2024 Dec 18;28(1):412. doi: 10.1186/s13054-024-05178-6.
2
Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support.在需要体外膜肺氧合（ECMO）支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征（Covid-19 ARDS）患者中复发性呼吸机相关性肺炎。
Ann Intensive Care. 2024 Apr 25;14(1):67. doi: 10.1186/s13613-024-01295-1.
3
Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making.
脓毒症管理：个体化决策背景下抗生素治疗的难题
J Pers Med. 2024 Jan 18;14(1):106. doi: 10.3390/jpm14010106.
4
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.一项评估7天与14天抗菌治疗对严重多重耐药革兰氏阴性菌感染疗效的随机、开放标签、非劣效性临床试验：OPTIMISE试验方案
Infect Dis Ther. 2024 Jan;13(1):237-250. doi: 10.1007/s40121-023-00897-9. Epub 2023 Dec 16.
5
Short-course antibiotic therapy for pneumonia in the neonatal intensive care unit.新生儿重症监护病房肺炎的短程抗生素治疗。
J Perinatol. 2023 Sep;43(9):1145-1151. doi: 10.1038/s41372-023-01720-6. Epub 2023 Jul 12.
6
Antibiotic stewardship in the ICU: time to shift into overdrive.重症监护病房的抗生素管理：是时候加速推进了。
Ann Intensive Care. 2023 May 6;13(1):39. doi: 10.1186/s13613-023-01134-9.
7
Comparison of a short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.短期与长期抗生素治疗呼吸机相关性肺炎的比较：随机对照试验的系统评价和荟萃分析
EClinicalMedicine. 2023 Mar 1;58:101880. doi: 10.1016/j.eclinm.2023.101880. eCollection 2023 Apr.